T1	intervention 10 31	anaesthetic technique
T2	eligibility 35 99	oestrogen receptor-negative breast cancer cell function in vitro
T3	intervention 840 884	propofol/paravertebral anaesthesia-analgesia
T4	intervention-participants 912 914	11
T5	control 919 950	sevoflurane general anaesthesia
T6	control-participants 996 998	11
T8	outcome 1240 1251	Pain scores
T9	outcome 1358 1399	proliferation of MDA-MB-231 cells treated
T12	outcome 1609 1660	change in MDA-MB-231 cell migration after treatment
T10	outcome 1263 1275	at 1 and 2 h
